Filing Flows › Agape ATP (ATPC) › Q1 2026
Agape ATP (ATPC) Q1 2026 earnings results (first quarter 2026)
10-Q filed May 15, 2026
Agape ATP (ATPC) reported revenue of $274K for the first quarter 2026 (Q1 2026), -5% from a year earlier and -31% from the quarter before. Operating margin was -247.5%, net loss $328K (119.7% of revenue).
Agape ATP, Q1 2026: revenue $274K (-5% year over year), operating margin -247.5%, net loss $328K, operating cash flow −$395K. The chart follows the revenue to costs, profit and cash.
| Q1 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $274K | -31% | -5% |
| Operating profit | −$677K | — | — |
| Net earnings | −$328K | — | — |
| Operating cash flow | −$395K | — | — |
What changed
Revenue was $274K in Q1 2026, down 5% year over year and down 31% from the previous quarter. Product Health Therapies was the largest line at 78% of revenue. Energized Mineral Concentrate lost $7K year over year (down 40%), 47% of the total change.
Gross margin was 58.3%, up 4.2 points from Q1 2025. Operating costs exceeded revenue by $677K, an operating margin of -247.5%. Operating expenses fell 5% while revenue fell 5%. The quarter ended with a net loss of $328K, narrower than the previous quarter's $376K loss. Non-operating items added $336K, -99% of pre-tax earnings, so the bottom line overstates operating performance.
Operating cash flow was −$395K. Non-cash charges added back $3K of depreciation and amortization. Working capital and other items used $70K.
Questions
What was Agape ATP's revenue in the first quarter 2026?
Agape ATP (ATPC) reported revenue of $274K for the first quarter 2026 (Q1 2026), -5% from a year earlier and -31% from the quarter before.
Was Agape ATP profitable in the first quarter 2026?
Operating loss was $677K (-247.5% of revenue) and net loss $328K.
Source: Agape ATP 10-Q on SEC EDGAR.